Market Overview

UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Boston Scientific Corporation

Share:
Related BSX
Mid-Afternoon Market Update: Crude Oil Up 1%; Five Below Shares Rise On Earnings Beat
15 Biggest Mid-Day Gainers For Friday
Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic (Investor's Business Daily)

In a report published Wednesday, Citigroup reiterated its Buy rating on Boston Scientific Corporation (NYSE: BSX), and slightly raised its price target from $7.30 to $8.20.

Citigroup noted, “BSX's shares have moved up significantly faster than we expected since last Thanksgiving, but we still see room for the stock on a fundamental basis as trends are improving and the peer group valuation has moved up. Plus, we still believe the call option on Durata being removed from the market is largely underappreciated.”

Boston Scientific Corporation closed on Tuesday at $7.10.

Latest Ratings for BSX

DateFirmActionFromTo
Oct 2016CitigroupMaintainsBuy
Sep 2016Argus ResearchUpgradesHoldBuy
Aug 2016CitigroupMaintainsBuy

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (BSX)

View Comments and Join the Discussion!